Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2026)
Ardelyx (ARDX) posted Amortization of Deferred Charges of $362000.0 for Q1 2026, up 1.4% on a QoQ basis from $357000.0 in Q4 2025, and down 60.78% year-over-year from $923000.0 in Q1 2025.
Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
Ardelyx's Amortization of Deferred Charges history runs 12 years deep, the most recent figure standing at $362000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 60.78% year-over-year to $362000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 65.2% YoY) and the FY2025 annual result came in at $1.9 million, down 51.42% from the prior year.
- Amortization of Deferred Charges was $362000.0 for Q1 2026 at Ardelyx, up from $357000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.0 million in Q4 2024 and bottomed at $331000.0 in Q2 2025.
- A 5-year average of $788117.6 and a median of $887000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 438.36% — and 2025, when it sank 67.06%.
- Ardelyx's Amortization of Deferred Charges stood at $887000.0 in 2022, then grew by 5.3% to $934000.0 in 2023, then grew by 10.81% to $1.0 million in 2024, then slumped by 65.51% to $357000.0 in 2025, then gained by 1.4% to $362000.0 in 2026.
- Business Quant data shows ARDX's Amortization of Deferred Charges at $362000.0 in Q1 2026, $357000.0 in Q4 2025, and $336000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,000.00 |
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | 357,000.00 |
| Dec 31, 2025 | 357,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 331,000.00 |
| Jun 30, 2025 | 331,000.00 |
| Mar 31, 2025 | 923,000.00 |
| Mar 31, 2025 | 923,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 948,000.00 |
| Mar 31, 2024 | 948,000.00 |
| Dec 31, 2023 | 934,000.00 |
| Dec 31, 2023 | 934,000.00 |